Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:DVLT NYSE:IBM NASDAQ:SCLX On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDVLTDatavault AI$1.36+24.8%$0.51$0.25▼$2.68$187.31M0.3599.92 million shs107.52 million shsIBMInternational Business Machines$286.46+1.5%$254.07$203.51▼$296.16$262.24B0.735.34 million shs4.38 million shsSCLXScilex$20.68+5.1%$20.08$3.60▼$39.90$136.89M1.36258,584 shs279,595 shsReduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDVLTDatavault AI-5.22%+47.64%+205.32%+53.52%+108,999,900.00%IBMInternational Business Machines+0.77%+3.62%+15.85%-1.95%+27.65%SCLXScilex-26.07%-31.67%+10.81%+215.38%-39.19%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeDVLTDatavault AI$1.36+24.8%$0.51$0.25▼$2.68$187.31M0.3599.92 million shs107.52 million shsIBMInternational Business Machines$286.46+1.5%$254.07$203.51▼$296.16$262.24B0.735.34 million shs4.38 million shsSCLXScilex$20.68+5.1%$20.08$3.60▼$39.90$136.89M1.36258,584 shs279,595 shsReduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceDVLTDatavault AI-5.22%+47.64%+205.32%+53.52%+108,999,900.00%IBMInternational Business Machines+0.77%+3.62%+15.85%-1.95%+27.65%SCLXScilex-26.07%-31.67%+10.81%+215.38%-39.19%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceDVLTDatavault AI 3.50Strong Buy$7.00414.71% UpsideIBMInternational Business Machines 2.44Hold$275.00-4.00% DownsideSCLXScilex 2.50Moderate Buy$455.002,100.19% UpsideCurrent Analyst Ratings BreakdownLatest DVLT, SCLX, and IBM Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails9/15/2025IBMInternational Business MachinesSanford C. BernsteinSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageMarket Perform$280.008/14/2025IBMInternational Business MachinesErste Group BankSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingDowngradeBuy ➝ Hold7/24/2025IBMInternational Business MachinesJPMorgan Chase & Co.Subscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetNeutral$244.00 ➝ $290.007/24/2025IBMInternational Business MachinesUBS GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetSell$195.00 ➝ $200.007/24/2025IBMInternational Business MachinesBank of AmericaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingLower Price TargetBuy$320.00 ➝ $310.007/18/2025IBMInternational Business MachinesBMO Capital MarketsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetMarket Perform$260.00 ➝ $300.007/17/2025IBMInternational Business MachinesRoyal Bank Of CanadaSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetOutperform$285.00 ➝ $315.007/16/2025IBMInternational Business MachinesStifel NicolausSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$290.00 ➝ $310.007/9/2025IBMInternational Business MachinesUBS GroupSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell$170.00 ➝ $195.007/7/2025IBMInternational Business MachinesMelius ResearchSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeStrong-Buy(Data available from 10/1/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookDVLTDatavault AI$4.44M52.66N/AN/A$1.65 per share0.82IBMInternational Business Machines$64.04B4.16$15.89 per share18.03$29.62 per share9.67SCLXScilex$56.59M2.54N/AN/A($27.68) per share-0.75Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateDVLTDatavault AI-$51.41MN/A0.00N/AN/A-1,309.82%-94.61%-71.54%N/AIBMInternational Business Machines$6.02B$6.1646.5024.694.319.11%37.62%7.08%10/22/2025 (Estimated)SCLXScilex-$72.81M-$29.02N/AN/AN/A-179.12%N/A-109.95%11/12/2025 (Estimated)Latest DVLT, SCLX, and IBM EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails10/22/2025Q3 2025IBMInternational Business Machines$2.43N/AN/AN/A$16.10 billionN/A8/19/2025Q2 2025DVLTDatavault AIN/A-$0.54N/A-$0.54N/A$1.74 million8/13/2025Q2 2025SCLXScilex-$4.55-$7.42-$2.87-$7.42$26.25 million$9.90 million7/23/2025Q2 2025IBMInternational Business Machines$2.65$2.80+$0.15$2.31$16.58 billion$16.98 billionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthDVLTDatavault AIN/AN/AN/AN/AN/AIBMInternational Business Machines$6.722.35%N/A109.09%30 YearsSCLXScilexN/AN/AN/AN/AN/ALatest DVLT, SCLX, and IBM DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date7/23/2025IBMInternational Business MachinesQuarterly$1.682.78%8/8/20258/8/20259/10/2025(Data available from 1/1/2013 forward)Compare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioDVLTDatavault AI0.510.470.30IBMInternational Business Machines2.000.910.87SCLXScilexN/A0.110.10Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipDVLTDatavault AI0.66%IBMInternational Business Machines58.96%SCLXScilex69.67%Insider OwnershipCompanyInsider OwnershipDVLTDatavault AI18.57%IBMInternational Business Machines0.18%SCLXScilex7.94%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableDVLTDatavault AI40171.84 million139.93 millionN/AIBMInternational Business Machines293,400929.40 million927.72 millionOptionableSCLXScilex806.96 million6.40 millionNo DataDVLT, SCLX, and IBM HeadlinesRecent News About These CompaniesDatavault AI: The New AI Contender Backed by Big Funding (SCLX)...4 hours ago | marketbeat.comScilex Holding Company Enters Warrant Exercise Agreement5 hours ago | tipranks.comDatavault AI (NASDAQ: DVLT) Closes Initial Tranche of $150M Bitcoin Investment from Scilex HoldingOctober 1 at 3:24 PM | financial-news.co.ukScilex Holding Company Completes Repurchase of 3.13 Million Warrants from Oramed Pharmaceuticals for $13 MillionOctober 1 at 9:31 AM | quiverquant.comQScilex Holding Company Announces the Completion of the First Tranche of the Oramed Pharmaceuticals, Inc. Warrant RepurchaseOctober 1 at 9:00 AM | globenewswire.comScilex Holding Company $SCLX Shares Bought by Goldman Sachs Group Inc.October 1 at 3:05 AM | marketbeat.comDatavault AI: Fresh Capital, Blue-Chip Partnership Back A Speculative BuySeptember 30 at 11:18 AM | seekingalpha.comScilex Enters Crypto Market with $200M Bitcoin DealSeptember 26, 2025 | tipranks.comScilex Holding Company Updates Board After Business MergerSeptember 26, 2025 | tipranks.comScilex Invests $150 Million in Datavault AISeptember 26, 2025 | tipranks.comDatavault AI Announces Closing of Initial Tranche Investment from Scilex Holding CompanySeptember 26, 2025 | businesswire.comScilex Holding Company Completes Initial Tranche of $150 Million Investment in Datavault AI Inc.September 26, 2025 | quiverquant.comQScilex Holding Company Announces Closing of Previously Announced Initial Tranche Investment in Datavault AISeptember 26, 2025 | globenewswire.comScilex to make $150M bitcoin investment in Datavault AISeptember 25, 2025 | msn.comScilex Holding Company Announces $150 Million Bitcoin Investment in Datavault AI Inc. to Accelerate Growth and InnovationSeptember 25, 2025 | quiverquant.comQScilex Holding Company Announces $150 Million Strategic Bitcoin Investment in Datavault AISeptember 25, 2025 | globenewswire.comScilex Announces Closing of Previously Announced Non-Dilutive Value Enhancing Transaction with an Institutional Investor for the Exchange of $200 Million of Common Stock of ...September 25, 2025 | finanznachrichten.deScilex Announces Closing of Previously Announced Non-Dilutive Value Enhancing Transaction with an Institutional Investor for the Exchange of $200 Million of Common Stock of Semnur Pharmaceuticals, Inc. Held by Scilex Holding Company for $200 Million in BitcoinSeptember 25, 2025 | globenewswire.comScilex enters MOU with Biconomy.com to collaborate on crypto strategySeptember 24, 2025 | msn.comScilex Holding Company Partners with Biconomy.com to Explore Cryptocurrency and Treasury Management StrategiesSeptember 24, 2025 | quiverquant.comQScilex Holding Company Announces It Has Entered into a Memorandum of Understanding with Biconomy.com to Collaborate on Future Cryptocurrency Strategies and Treasury ManagementSeptember 24, 2025 | globenewswire.comNew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesSoundHound Breaks Critical Resistance: How High Can It Get Now?By Thomas Hughes | September 28, 2025Why Datavault May Be the Penny AI Stock Investors Have Waited ForBy Nathan Reiff | September 22, 20253 Hot Tech Stocks With Bullish Charts and Ample UpsideBy Thomas Hughes | September 15, 2025Oracle Has Spoken: AI Changes EverythingBy Thomas Hughes | September 10, 2025Datavault AI: The New AI Contender Backed by Big FundingBy Jeffrey Neal Johnson | October 1, 2025DVLT, SCLX, and IBM Company DescriptionsDatavault AI NASDAQ:DVLT$1.36 +0.27 (+24.77%) As of 04:00 PM EasternDatavault AI Inc., a data sciences technology company, owns and operates data management and supercomputer platforms. It offers data technology and software solutions. The company was formerly known as WiSA Technologies, Inc. and changed its name to Datavault AI Inc. in February 2025. Datavault AI Inc. was incorporated in 2010 and is headquartered in Beaverton, Oregon.International Business Machines NYSE:IBM$286.46 +4.30 (+1.52%) Closing price 03:59 PM EasternExtended Trading$286.41 -0.05 (-0.02%) As of 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.International Business Machines Corporation, together with its subsidiaries, provides integrated solutions and services worldwide. The company operates through Software, Consulting, Infrastructure, and Financing segments. The Software segment offers a hybrid cloud and AI platforms that allows clients to realize their digital and AI transformations across the applications, data, and environments in which they operate. The Consulting segment focuses on skills integration for strategy, experience, technology, and operations by domain and industry. The Infrastructure segment provides on-premises and cloud based server, and storage solutions, as well as life-cycle services for hybrid cloud infrastructure deployment. The Financing segment offers client and commercial financing, facilitates IBM clients' acquisition of hardware, software, and services. The company has a strategic partnership to various companies including hyperscalers, service providers, global system integrators, and software and hardware vendors that includes Adobe, Amazon Web services, Microsoft, Oracle, Salesforce, Samsung Electronics and SAP, and others. The company was formerly known as Computing-Tabulating-Recording Co. International Business Machines Corporation was incorporated in 1911 and is headquartered in Armonk, New York.Scilex NASDAQ:SCLX$20.68 +1.00 (+5.08%) Closing price 04:00 PM EasternExtended Trading$20.71 +0.03 (+0.15%) As of 07:29 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Scilex Holding Company focuses on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. Its commercial products include ZTlido (lidocaine topical system) 1.8% (ZTlido), a prescription lidocaine topical product for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a ready-to-use oral solution for the acute treatment of migraine with or without aura in adults; and GLOPERBA, a liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults. The company is also developing three product candidates, including SP-102 (10 mg dexamethasone sodium phosphate viscous gel) (SEMDEXA), a novel viscous gel formulation of a used corticosteroid for epidural injections, which has completed a Phase 3 study to treat lumbosacral radicular pain or sciatica; SP-103 (lidocaine topical system) 5.4% (SP-103), a formulation of ZTlido for the treatment of chronic neck pain and low back pain (LBP) that has completed a Phase 2 trial; and SP-104 (4.5 mg low-dose naltrexone hydrochloride delayed-release capsules) (SP-104), a novel low-dose delayed-release naltrexone hydrochloride, which has completed Phase 1 trials for the treatment of fibromyalgia. The company is headquartered in Palo Alto, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Datavault AI: The New AI Contender Backed by Big Funding CoreWeave: Why the New King of AI Infrastructure Has Room to Run Palantir Stock Eyes New Highs, Boosted by Boeing Partnership Is Draganfly's Army Partnership a Game-Changer for Investors? Etsy Partners With OpenAI—What It Means for Investors Now Is Tilray's Stock Price Surge a Pipe Dream of Political Hype? Lamb Weston: Is the King of Spuds a Buy or a Dud for 2026? Lithium Americas Stock Exploded Last Week—Here’s Why Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
